"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","treatment_protocol_ch1","growth_protocol_ch1","molecule_ch1","extract_protocol_ch1","extract_protocol_ch1.1","taxid_ch1","description","data_processing","data_processing.1","data_processing.2","data_processing.3","data_processing.4","platform_id","contact_name","contact_email","contact_laboratory","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","data_row_count","instrument_model","library_selection","library_source","library_strategy","relation","relation.1","supplementary_file_1","cell type:ch1","cellular portion:ch1","genotype/variation:ch1","passages:ch1"
"GSM2835764","EKVX-Scrb-1","GSM2835764","Public on Oct 30 2017","Oct 30 2017","May 15 2019","SRA","1","Lung epithelial cells","Homo sapiens","cell type: Carcinoma cells","cellular portion: Exosomes","genotype/variation: wild-type","passages: 6-8","None","EKVX-cells were plated in T-25 flask at 2x106 density and cultivated in Dulbecco's minimal essential medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 mg/mL streptomycin at 37°C in 5% CO2 overnight. Then, cells were washed 3 times with PBS and cultured in DMEM media supplemented with 10% exosome-depleted FBS (System Biosciences, Inc. (SBI), Palo Alto, CA) for 48 hours","total RNA","Exosomes were isolated from cell culture media using using ExoQuick-TCTM (SBI), and microRNA was purified using QIAGEN miRNeasy micro kit (QIAGEN, Valencia, CA) per the manufacture’s protocols","Libraries were prepared according to standard Ilumina's instructions","9606","EKVX Cntl-1","miRNA sequencing short reads were aligned to human reference genome (GRCh38) using Bowtie2 (v2.2.3) ;","Aligned sequences were mapped to mature miRNAs with annotation from miRBase (v.21);","The relative expression abundances of miRNAs were calculated as Count-Per-Million (CPM).","Genome_build: GRCh38","Supplementary_files_format_and_content: CPM","GPL16791","Tanyalak,,Parimon","tanyalak.parimon@cshs.org","Peter Chen","Medicine","Cedars-Sinai Medical Center","127 San Vicente","Los Angeles","CA","90048","USA","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07945889","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3342255","NONE","Carcinoma cells","Exosomes","wild-type","6-8"
"GSM2835765","EKVX-Scrb-2","GSM2835765","Public on Oct 30 2017","Oct 30 2017","May 15 2019","SRA","1","Lung epithelial cells","Homo sapiens","cell type: Carcinoma cells","cellular portion: Exosomes","genotype/variation: wild-type","passages: 6-8","None","EKVX-cells were plated in T-25 flask at 2x106 density and cultivated in Dulbecco's minimal essential medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 mg/mL streptomycin at 37°C in 5% CO2 overnight. Then, cells were washed 3 times with PBS and cultured in DMEM media supplemented with 10% exosome-depleted FBS (System Biosciences, Inc. (SBI), Palo Alto, CA) for 48 hours","total RNA","Exosomes were isolated from cell culture media using using ExoQuick-TCTM (SBI), and microRNA was purified using QIAGEN miRNeasy micro kit (QIAGEN, Valencia, CA) per the manufacture’s protocols","Libraries were prepared according to standard Ilumina's instructions","9606","EKVX Cntl-2","miRNA sequencing short reads were aligned to human reference genome (GRCh38) using Bowtie2 (v2.2.3) ;","Aligned sequences were mapped to mature miRNAs with annotation from miRBase (v.21);","The relative expression abundances of miRNAs were calculated as Count-Per-Million (CPM).","Genome_build: GRCh38","Supplementary_files_format_and_content: CPM","GPL16791","Tanyalak,,Parimon","tanyalak.parimon@cshs.org","Peter Chen","Medicine","Cedars-Sinai Medical Center","127 San Vicente","Los Angeles","CA","90048","USA","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07945894","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3342256","NONE","Carcinoma cells","Exosomes","wild-type","6-8"
"GSM2835766","EKVX-Scrb-3","GSM2835766","Public on Oct 30 2017","Oct 30 2017","May 15 2019","SRA","1","Lung epithelial cells","Homo sapiens","cell type: Carcinoma cells","cellular portion: Exosomes","genotype/variation: wild-type","passages: 6-8","None","EKVX-cells were plated in T-25 flask at 2x106 density and cultivated in Dulbecco's minimal essential medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 mg/mL streptomycin at 37°C in 5% CO2 overnight. Then, cells were washed 3 times with PBS and cultured in DMEM media supplemented with 10% exosome-depleted FBS (System Biosciences, Inc. (SBI), Palo Alto, CA) for 48 hours","total RNA","Exosomes were isolated from cell culture media using using ExoQuick-TCTM (SBI), and microRNA was purified using QIAGEN miRNeasy micro kit (QIAGEN, Valencia, CA) per the manufacture’s protocols","Libraries were prepared according to standard Ilumina's instructions","9606","EKVX Cntl-3","miRNA sequencing short reads were aligned to human reference genome (GRCh38) using Bowtie2 (v2.2.3) ;","Aligned sequences were mapped to mature miRNAs with annotation from miRBase (v.21);","The relative expression abundances of miRNAs were calculated as Count-Per-Million (CPM).","Genome_build: GRCh38","Supplementary_files_format_and_content: CPM","GPL16791","Tanyalak,,Parimon","tanyalak.parimon@cshs.org","Peter Chen","Medicine","Cedars-Sinai Medical Center","127 San Vicente","Los Angeles","CA","90048","USA","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07945893","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3342257","NONE","Carcinoma cells","Exosomes","wild-type","6-8"
"GSM2835767","EKVX-1735-1","GSM2835767","Public on Oct 30 2017","Oct 30 2017","May 15 2019","SRA","1","Lung epithelial cells","Homo sapiens","cell type: Carcinoma cells","cellular portion: Exosomes","genotype/variation: syndecan-1 knock-down","passages: 6-8","None","EKVX-cells were plated in T-25 flask at 2x106 density and cultivated in Dulbecco's minimal essential medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 mg/mL streptomycin at 37°C in 5% CO2 overnight. Then, cells were washed 3 times with PBS and cultured in DMEM media supplemented with 10% exosome-depleted FBS (System Biosciences, Inc. (SBI), Palo Alto, CA) for 48 hours","total RNA","Exosomes were isolated from cell culture media using using ExoQuick-TCTM (SBI), and microRNA was purified using QIAGEN miRNeasy micro kit (QIAGEN, Valencia, CA) per the manufacture’s protocols","Libraries were prepared according to standard Ilumina's instructions","9606","EKVX KO-1","miRNA sequencing short reads were aligned to human reference genome (GRCh38) using Bowtie2 (v2.2.3) ;","Aligned sequences were mapped to mature miRNAs with annotation from miRBase (v.21);","The relative expression abundances of miRNAs were calculated as Count-Per-Million (CPM).","Genome_build: GRCh38","Supplementary_files_format_and_content: CPM","GPL16791","Tanyalak,,Parimon","tanyalak.parimon@cshs.org","Peter Chen","Medicine","Cedars-Sinai Medical Center","127 San Vicente","Los Angeles","CA","90048","USA","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07945892","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3342258","NONE","Carcinoma cells","Exosomes","syndecan-1 knock-down","6-8"
"GSM2835768","EKVX-1735-2","GSM2835768","Public on Oct 30 2017","Oct 30 2017","May 15 2019","SRA","1","Lung epithelial cells","Homo sapiens","cell type: Carcinoma cells","cellular portion: Exosomes","genotype/variation: syndecan-1 knock-down","passages: 6-8","None","EKVX-cells were plated in T-25 flask at 2x106 density and cultivated in Dulbecco's minimal essential medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 mg/mL streptomycin at 37°C in 5% CO2 overnight. Then, cells were washed 3 times with PBS and cultured in DMEM media supplemented with 10% exosome-depleted FBS (System Biosciences, Inc. (SBI), Palo Alto, CA) for 48 hours","total RNA","Exosomes were isolated from cell culture media using using ExoQuick-TCTM (SBI), and microRNA was purified using QIAGEN miRNeasy micro kit (QIAGEN, Valencia, CA) per the manufacture’s protocols","Libraries were prepared according to standard Ilumina's instructions","9606","EKVX KO-2","miRNA sequencing short reads were aligned to human reference genome (GRCh38) using Bowtie2 (v2.2.3) ;","Aligned sequences were mapped to mature miRNAs with annotation from miRBase (v.21);","The relative expression abundances of miRNAs were calculated as Count-Per-Million (CPM).","Genome_build: GRCh38","Supplementary_files_format_and_content: CPM","GPL16791","Tanyalak,,Parimon","tanyalak.parimon@cshs.org","Peter Chen","Medicine","Cedars-Sinai Medical Center","127 San Vicente","Los Angeles","CA","90048","USA","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07945891","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3342259","NONE","Carcinoma cells","Exosomes","syndecan-1 knock-down","6-8"
"GSM2835769","EKVX-1735-3","GSM2835769","Public on Oct 30 2017","Oct 30 2017","May 15 2019","SRA","1","Lung epithelial cells","Homo sapiens","cell type: Carcinoma cells","cellular portion: Exosomes","genotype/variation: syndecan-1 knock-down","passages: 6-8","None","EKVX-cells were plated in T-25 flask at 2x106 density and cultivated in Dulbecco's minimal essential medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 mg/mL streptomycin at 37°C in 5% CO2 overnight. Then, cells were washed 3 times with PBS and cultured in DMEM media supplemented with 10% exosome-depleted FBS (System Biosciences, Inc. (SBI), Palo Alto, CA) for 48 hours","total RNA","Exosomes were isolated from cell culture media using using ExoQuick-TCTM (SBI), and microRNA was purified using QIAGEN miRNeasy micro kit (QIAGEN, Valencia, CA) per the manufacture’s protocols","Libraries were prepared according to standard Ilumina's instructions","9606","EKVX KO-3","miRNA sequencing short reads were aligned to human reference genome (GRCh38) using Bowtie2 (v2.2.3) ;","Aligned sequences were mapped to mature miRNAs with annotation from miRBase (v.21);","The relative expression abundances of miRNAs were calculated as Count-Per-Million (CPM).","Genome_build: GRCh38","Supplementary_files_format_and_content: CPM","GPL16791","Tanyalak,,Parimon","tanyalak.parimon@cshs.org","Peter Chen","Medicine","Cedars-Sinai Medical Center","127 San Vicente","Los Angeles","CA","90048","USA","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07945890","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3342260","NONE","Carcinoma cells","Exosomes","syndecan-1 knock-down","6-8"
